The likelihood and intensity depend on your dose and other factors specific to you
Study participants We identified all adult (aged 20 years) patients with NAFLD and type 2 diabetes who had newly started treatment with non-insulin glucose-lowering drugs (metformin, GLP-1RAs, SGLT2 inhibitors, sulfonylureas, meglitinides, thiazolidinediones, acarbose or dipeptidyl peptidase-4 inhibitors) between 1 January 2013 and 31 December 2021
accordingly, choosing an appropriate course of therapy is more difficult
doi:10.1007/s00330-020-06960-0 Gross PW, Jones RH, Beber SA, Farrell AM, Fabricant PD
Current evidence does not support routine clinical use of GLP-1 medications specifically for alcohol cravings, and patients with alcohol use disorder should be referred to evidence-based treatments including behavioral interventions, mutual support groups, and FDA-approved pharmacotherapies such as naltrexone, acamprosate, and disulfiram
Postpartum weight loss and hair loss combo
